Dylan M. Zylla

2.1k total citations
34 papers, 806 citations indexed

About

Dylan M. Zylla is a scholar working on Psychiatry and Mental health, Oncology and Pharmacology. According to data from OpenAlex, Dylan M. Zylla has authored 34 papers receiving a total of 806 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Psychiatry and Mental health, 11 papers in Oncology and 10 papers in Pharmacology. Recurrent topics in Dylan M. Zylla's work include Cannabis and Cannabinoid Research (10 papers), Cancer, Stress, Anesthesia, and Immune Response (8 papers) and Cancer survivorship and care (7 papers). Dylan M. Zylla is often cited by papers focused on Cannabis and Cannabinoid Research (10 papers), Cancer, Stress, Anesthesia, and Immune Response (8 papers) and Cancer survivorship and care (7 papers). Dylan M. Zylla collaborates with scholars based in United States and Canada. Dylan M. Zylla's co-authors include Pankaj Gupta, Michael A. Kuskowski, Kalpna Gupta, Tom Arneson, Timothy J Wilt, Roderick MacDonald, Frank A. Lederle, Pankaj Gupta, Sonja Boatman and Derek Vang and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Internal Medicine and Cancer.

In The Last Decade

Dylan M. Zylla

33 papers receiving 791 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dylan M. Zylla United States 15 270 184 157 145 135 34 806
Rebecca E. Wrishko United States 16 249 0.9× 131 0.7× 33 0.2× 146 1.0× 74 0.5× 36 989
Paul Farquhar-Smith United Kingdom 15 80 0.3× 190 1.0× 268 1.7× 180 1.2× 156 1.2× 35 1.1k
Tess E Cooper Australia 17 80 0.3× 183 1.0× 57 0.4× 166 1.1× 339 2.5× 41 945
Lee L. Lanza United States 12 361 1.3× 146 0.8× 22 0.1× 208 1.4× 35 0.3× 17 1.1k
Walter Tirelli Italy 11 55 0.2× 96 0.5× 152 1.0× 180 1.2× 262 1.9× 15 779
W Król United States 12 112 0.4× 74 0.4× 44 0.3× 241 1.7× 42 0.3× 22 1.3k
Jamie N. Brown United States 19 92 0.3× 50 0.3× 50 0.3× 105 0.7× 54 0.4× 69 911
Elaine Boland United Kingdom 18 66 0.2× 89 0.5× 253 1.6× 115 0.8× 166 1.2× 42 844
Shayne N. Freemantle United Kingdom 14 212 0.8× 144 0.8× 32 0.2× 81 0.6× 170 1.3× 22 778
Kathrin Jobski Germany 13 150 0.6× 62 0.3× 19 0.1× 32 0.2× 47 0.3× 37 517

Countries citing papers authored by Dylan M. Zylla

Since Specialization
Citations

This map shows the geographic impact of Dylan M. Zylla's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dylan M. Zylla with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dylan M. Zylla more than expected).

Fields of papers citing papers by Dylan M. Zylla

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dylan M. Zylla. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dylan M. Zylla. The network helps show where Dylan M. Zylla may publish in the future.

Co-authorship network of co-authors of Dylan M. Zylla

This figure shows the co-authorship network connecting the top 25 collaborators of Dylan M. Zylla. A scholar is included among the top collaborators of Dylan M. Zylla based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dylan M. Zylla. Dylan M. Zylla is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Ziegenfuss, Jeanette Y., Helen M. Parsons, Anne Blaes, et al.. (2024). Data quality in a survey of registered medical cannabis users with cancer: nonresponse and measurement error. JNCI Monographs. 2024(66). 218–223. 1 indexed citations
4.
Moore, Heather, Marcus D. Goncalves, Erica L. Mayer, et al.. (2024). Effective Strategies for the Prevention and Mitigation of Phosphatidylinositol-3-Kinase Inhibitor-Associated Hyperglycemia: Optimizing Patient Care. Clinical Breast Cancer. 25(1). 1–11. 3 indexed citations
5.
Agarwal, Neeraj, Catherine M. Tangen, Maha Hussain, et al.. (2022). Orteronel for Metastatic Hormone-Sensitive Prostate Cancer: A Multicenter, Randomized, Open-Label Phase III Trial (SWOG-1216). Journal of Clinical Oncology. 40(28). 3301–3309. 30 indexed citations
6.
Zylla, Dylan M., Grace Gilmore, Gabriela Vazquez‐Benitez, et al.. (2021). A randomized trial of medical cannabis in patients with stage IV cancers to assess feasibility, dose requirements, impact on pain and opioid use, safety, and overall patient satisfaction. Supportive Care in Cancer. 29(12). 7471–7478. 38 indexed citations
7.
Gilmore, Grace, et al.. (2021). Cannabis as an Anticancer Agent: A Review of Clinical Data and Assessment of Case Reports. Cannabis and Cannabinoid Research. 7(1). 24–33. 25 indexed citations
8.
Stover, Angela M., Benjamin Y. Urick, Allison M. Deal, et al.. (2019). ON5 DEVELOPMENT AND TESTING OF PATIENT-REPORTED OUTCOME PERFORMANCE MEASURES (PRO-PMS) FOR COMPARING ONCOLOGY PRACTICES. Value in Health. 22. S413–S413. 1 indexed citations
9.
Zylla, Dylan M., et al.. (2019). Impact of diabetes and hyperglycemia on health care utilization, infection risk, and survival in patients with cancer receiving glucocorticoids with chemotherapy. Journal of Diabetes and its Complications. 33(4). 335–339. 22 indexed citations
10.
Arneson, Tom, et al.. (2019). A Comprehensive Review of Cannabis in Patients with Cancer: Availability in the USA, General Efficacy, and Safety. Current Oncology Reports. 21(1). 10–10. 30 indexed citations
11.
Zylla, Dylan M., Grace Gilmore, Gabriela Vazquez‐Benitez, et al.. (2019). A randomized trial of medical cannabis (MC) in patients with advanced cancer (AC) to assess impact on opioid use and cancer-related symptoms.. Journal of Clinical Oncology. 37(31_suppl). 109–109. 2 indexed citations
12.
Stover, Angela M., Allison M. Deal, Jennifer Jansen, et al.. (2019). Development and testing of patient-reported outcome performance measures (PRO-PMs) for oncology practice.. Journal of Clinical Oncology. 37(27_suppl). 173–173. 1 indexed citations
13.
Zylla, Dylan M., et al.. (2018). Oncology Clinicians and the Minnesota Medical Cannabis Program: A Survey on Medical Cannabis Practice Patterns, Barriers to Enrollment, and Educational Needs. Cannabis and Cannabinoid Research. 3(1). 195–202. 46 indexed citations
14.
Zylla, Dylan M., et al.. (2018). Impact of opioid use on health care utilization and survival in patients with newly diagnosed stage IV malignancies. Supportive Care in Cancer. 26(7). 2259–2266. 20 indexed citations
15.
Zylla, Dylan M., et al.. (2017). Establishment of Personalized Pain Goals in Oncology Patients to Improve Care and Decrease Costs. Journal of Oncology Practice. 13(3). e266–e272. 8 indexed citations
16.
Zylla, Dylan M., et al.. (2017). A systematic review of the impact of pain on overall survival in patients with cancer. Supportive Care in Cancer. 25(5). 1687–1698. 62 indexed citations
17.
Zylla, Dylan M., Michael A. Kuskowski, Kalpna Gupta, & Pankaj Gupta. (2014). Association of opioid requirement and cancer pain with survival in advanced non-small cell lung cancer.. Journal of Clinical Oncology. 32(31_suppl). 183–183. 1 indexed citations
18.
Zylla, Dylan M., Michael A. Kuskowski, Kalpna Gupta, & Pankaj Gupta. (2014). Association of opioid requirement and cancer pain with survival in advanced non-small cell lung cancer. British Journal of Anaesthesia. 113(Suppl 1). i109–i116. 81 indexed citations
19.
Zylla, Dylan M., Kelly Cawcutt, D. M. Musher, et al.. (2012). Pneumococcal Pyomyositis: Report of 2 Cases and Review of the Literature. Clinical Infectious Diseases. 55(3). e12–e17. 8 indexed citations
20.
Zylla, Dylan M., Yuan Li, Jeffrey D. Merrill, et al.. (2003). CCR5 Expression and β-Chemokine Production During Placental Neonatal Monocyte Differentiation. Pediatric Research. 53(5). 853–858. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rebecca E. Wrishko Breakdown of academic impact, for papers by Paul Farquhar-Smith Breakdown of academic impact, for papers by Tess E Cooper Breakdown of academic impact, for papers by Lee L. Lanza Breakdown of academic impact, for papers by Walter Tirelli Breakdown of academic impact, for papers by W Król Breakdown of academic impact, for papers by Jamie N. Brown Breakdown of academic impact, for papers by Elaine Boland Breakdown of academic impact, for papers by Shayne N. Freemantle Breakdown of academic impact, for papers by Kathrin Jobski
Rankless by CCL
2026